Dagmara Curylo-Zimowska
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 16, 2025
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes.
Journal: Scientific reports
Published: March 31, 2025
Immediate Response to Brentuximab Vedotin in a Patient with Localized MF-LCT.
Journal: Case reports in dermatology
Published: October 01, 2022
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?
Journal: The Journal of dermatological treatment
Published: September 14, 2020
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Journal: British journal of haematology
Published: August 12, 2019
Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
Journal: Polish archives of internal medicine
Published: April 05, 2019
Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group.
Journal: Polskie Archiwum Medycyny Wewnetrznej
Published: September 04, 2015
Hematological toxicity of radioimmunotherpy with 90Y Ibritumomab
Journal: Przeglad lekarski
Published: July 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026